annatto has been researched along with Bone Loss, Perimenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, KY; Ima-Nirwana, S; Mohamad, NV | 2 |
2 other study(ies) available for annatto and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Self-emulsified annatto tocotrienol improves bone histomorphometric parameters in a rat model of oestrogen deficiency through suppression of skeletal sclerostin level and RANKL/OPG ratio.
Topics: Animals; Bixaceae; Bone and Bones; Bone Density; Bone Morphogenetic Proteins; Carotenoids; Disease Models, Animal; Emulsions; Estradiol; Female; Genetic Markers; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; Plant Extracts; RANK Ligand; Rats; Rats, Sprague-Dawley; Signal Transduction; Tocotrienols | 2021 |
Therapeutic potential of annatto tocotrienol with self-emulsifying drug delivery system in a rat model of postmenopausal bone loss.
Topics: Absorptiometry, Photon; Animals; Bixaceae; Bone and Bones; Bone Density Conservation Agents; Calcium; Carotenoids; Drug Delivery Systems; Emulsions; Female; Humans; Malondialdehyde; Osteoporosis, Postmenopausal; Ovariectomy; Plant Extracts; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tocotrienols; X-Ray Microtomography | 2021 |